CrossRef

Management of chronic viral hepatitis in the hematological patient

Expert Review of Anti-infective Therapy 16(3) (2018)

Laura Ambra Nicolini; Emanuela Zappulo; Claudio Viscoli; Malgorzata Mikulska

Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT

iScience 26(3) (2023)

Jinhua Ren; QiaoXian Lin; Qi Chen; Jingjing Xu; Dabin Chen; Renli Chen; Kangni Lin; Haojie Zhu; Chenjing Ye; Xiaofeng Luo; Shaozhen Chen; Hui Kong; Qiong Lin; Nan Li; Xu Lin; Zhizhe Chen; Jianda Hu; Ting Yang

Immune phase transition under steroid treatment

Physical Review E 103(6) (2021)

Sonali Priyadarshini Nayak; Susmita Roy

Prevalence and serological profile of occult hepatitis B virus infection in newly diagnosed cancer patients

Indian Journal of Medical Microbiology 63 (2026)

Subhashree Sahu; Shilpee Kumar; Deepthi Nair

Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens

World Journal of Gastroenterology 30(44) (2024)

Rui Lu; Meng Zhang; Zi-Han Liu; Miao Hao; Yan Tian; Mei Li; Feng-Ping Wu; Wen-Jun Wang; Juan-Juan Shi; Xin Zhang; Xiao-Li Jia; Zi-Cheng Jiang; Xue-Mei Li; Guang-Hua Xu; Ya-Ping Li; Shuang-Suo Dang

The possible role of interleukin-35 and its therapeutic potential in pemphigus

International Immunopharmacology 42 (2017)

Soheil Tavakolpour; Forough Kheiry; Hajar Sadat Mirsafaei; Meisam Akhlaghdoust

Iranian guideline for rituximab therapy in pemphigus patients

Dermatologic Therapy 32(5) (2019)

Maryam Daneshpazhooh; Kamran Balighi; Hamidreza Mahmoudi; Soheil Tavakolpour; Robabeh Abedini; Tahereh Soori; Amir‐Houshang Ehsani; Maryam Ghiasi; Pedram Noormohammadpour; Narges Ghandi; Vahideh Lajevardi; Ali Sadeghinia; Maryam Nasimi; Arghavan Azizpour; Cheyda Chams‐Davatchi

Liver Illness and Psoriatic Patients

BioMed Research International 2018 (2018)

Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Damiani

Immune response to occult hepatitis B virus infection among hemodialysis patients: A review

The Microbe 5 (2024)

Ali Mussa; Nor Hayati Ismail; Nazmul Huda Syed; Mustafa Talib; Alaa Siddig; Rosline Hassan; Rohimah Mohamud; Nik Haszroel Hysham Nik Hashim

SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection

Journal of Clinical Virology Plus 3(4) (2023)

Shahrzad Shoraka; Seyed Reza Mohebbi; Seyed Masoud Hosseini; Amir Ghaemi; Mohammad Reza Zali

Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis

Hepatitis Monthly 16(4) (2016)

Soheil Tavakolpour; Shahnaz Sali

Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences

Expert Opinion on Biological Therapy 17(8) (2017)

Priyanka Vashisht; James O’dell

Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy

Cutaneous and Ocular Toxicology 44(1) (2025)

Ayşegül Tel Kankılıç; Ömer Karakoyun; Erhan Ayhan

Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study

Journal of Infection and Chemotherapy 27(10) (2021)

Hitoshi Yonezawa; Shingo Tanaka; Momoko Furuya; Koji Yamada; Koichi Asanuma; Yoshihiro Fujiya; Koji Miyanishi; Satoshi Takahashi; Junji Kato

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Blood 133(2) (2019)

Shigeru Kusumoto; Luca Arcaini; Xiaonan Hong; Jie Jin; Won Seog Kim; Yok Lam Kwong; Marion G. Peters; Yasuhito Tanaka; Andrew D. Zelenetz; Hiroshi Kuriki; Günter Fingerle-Rowson; Tina Nielsen; Eisuke Ueda; Hanna Piper-Lepoutre; Gila Sellam; Kensei Tobinai

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19

Pathogens 11(5) (2022)

Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Alessandra Borsetti; Massimo Ciccozzi; Evangelista Sagnelli

Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study

Infection and Drug Resistance Volume 15 (2022)

Pei He; Jie Xia; Peixin Zhang; Wensu Yang; Zhaoxin Xia; Ping Liu; Yi Zhu; Yaping Fang; Zhenhua Zhang; Jilu Shen

The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence

Cancer Treatment Reviews 86 (2020)

G. Tapia Rico; M.M. Chan; K.F. Loo

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

Archives of Dermatological Research 310(2) (2018)

Soheil Tavakolpour

Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

Cancer Science 111(11) (2020)

Shu‐Kui Qin; Qing Li; Jian Ming Xu; Jun Liang; Ying Cheng; Ying Fan; Jun Jiang; Hao Ye; Huimin Tao; Lian Li; Limin Zheng; Zhaohui Wei; Shu Li; Kun Meng; Bin Ye; Yan Sun

Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study

World Journal of Virology 13(1) (2024)

Nayana Sudevan; Manish Manrai; T V S V G K Tilak; Harshit Khurana; Harikrishnan Premdeep

Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation

Journal of Clinical Medicine 14(6) (2025)

Anissa Paschereit; Vivien Greese; Kayo Sakurayama; Michael Duerr; Fabian Halleck; Lutz Liefeldt; Mira Choi; Klemens Budde; Marcel G. Naik

Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections

Blood Reviews 32(5) (2018)

Talal Hilal; Juan C. Gea-Banacloche; Jose F. Leis

Untitled

The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study

Cancers 17(21) (2025)

Zhao-Xing Li; Dong-Li Liu; Lei Hu; Bai-Qing Peng; Xiu-Quan Qu; Li-Yuan Mu; Xiao-Chun Cheng; Pu Qiu; Yu-Xuan Huang; Xi-Rui Li; Ling-Quan Kong

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy

Immunology Letters 190 (2017)

Soheil Tavakolpour; Hajar Sadat Mirsafaei; Somayeh Elkaei Behjati; Mojtaba Ghasemiadl; Meisam Akhlaghdoust; Shahnaz Sali

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma

Journal of Investigative Medicine High Impact Case Reports 5(2) (2017)

Alisse Hannaford; David Del Bello; Siyang Leng; Ajai Chari; Ponni Perumalswami; Douglas Dieterich; Andrea Branch

Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases

Animals 15(16) (2025)

Marcin Kondracki; Andrzej Żmuda; Magdalena Gryzinska; Ilona Mazurkiewicz; Beata Seremak; Jacek Furmaga; Andrzej Jakubczak

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

PLOS ONE 12(9) (2017)

María Buti; María L. Manzano; Rosa M. Morillas; Montserrat García-Retortillo; Leticia Martín; Martín Prieto; María L. Gutiérrez; Emilio Suárez; Mariano Gómez Rubio; Javier López; Pilar Castillo; Manuel Rodríguez; José M. Zozaya; Miguel A. Simón; Luis E. Morano; José L. Calleja; María Yébenes; Rafael Esteban; Vincent Wong

Anti-TNF alfa kullanan hastalarda hepatit B reaktivasyonunun değerlendirilmesi

Dicle Tıp Dergisi 46(3) (2019)

İlkay BOZKURT; Ahmet BEKTAŞ

Tenofovir Alafenamide: A New Drug With Various Ambiguous Aspects in Treatment of Chronic Hepatitis B Infection

Archives of Clinical Infectious Diseases In Press(In Press) (2019)

Soheil Tavakolpour; Mohammad Darvishi; Shahnaz Sali